Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 16, 2022; 10(20): 7163-7170
Published online Jul 16, 2022. doi: 10.12998/wjcc.v10.i20.7163
Published online Jul 16, 2022. doi: 10.12998/wjcc.v10.i20.7163
Nursing a patient with latent autoimmune diabetes in adults with insulin-related lipodystrophy, allergy, and exogenous insulin autoimmune syndrome: A case report
Fang He, Ling-Ling Xu, Yu-Xiu Li, Ya-Xiu Dong, Department of Endocrinology, Peking Union Medical College Hospital, Beijing 100730, China
Author contributions: He F and Xu LL set the concept of the study; He F designed and drafted the paper, and performed analysis of the paper; Dong YX contributed to completing the survey of nurse; and Xu LL and Li YX contributed in revising the draft and approval of the final version.
Informed consent statement: The patient provided informed written consent for the publication of this case report.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ling-Ling Xu, MD, Chief Doctor, Department of Endocrinology, Peking Union Medical College Hospital, Shuaifuyuan Street, Beijing 100730, China. llxuwsh@163.com
Received: January 27, 2022
Peer-review started: January 27, 2022
First decision: March 23, 2022
Revised: March 30, 2022
Accepted: May 22, 2022
Article in press: May 22, 2022
Published online: July 16, 2022
Peer-review started: January 27, 2022
First decision: March 23, 2022
Revised: March 30, 2022
Accepted: May 22, 2022
Article in press: May 22, 2022
Published online: July 16, 2022
Core Tip
Core Tip: Latent autoimmune diabetes in adults (LADA) patients will have a need for exogenous insulin eventually. Once patients have developed insulin allergy, clinical treatment and nursing care become very challenging. We report a case of LADA with insulin-related lipodystrophy, allergy, and exogenous insulin autoimmune syndrome during insulin treatment. We successfully assisted the doctor to select a suitable form of insulin for timely skin testing and desensitization treatment. We describe the management of this patient from a nursing viewpoint. Here, we summarize the nursing experience of a case with complex insulin allergy requiring desensitization treatment.